January 6, 2021
January 6, 2021

American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols

Do you like it?
Read more
December 1, 2020
December 1, 2020

American CryoStem Announces Patient Recruitment and Additional Sub-Investigator for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial

Do you like it?
Read more
September 23, 2020
September 23, 2020

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial

Do you like it?
Read more
June 29, 2020
June 29, 2020

American CryoStem Announces the Conversion of Debenture into Equity and Sale into the Market

Do you like it?
Read more
April 2, 2020
April 2, 2020

American CryoStem to Develop ATCELL™ Clinical Study for Duchene Muscular Dystrophy with RACEMD

Do you like it?
Read more
December 5, 2019
December 5, 2019

American CryoStem Corporation Issues Shareholder Letter

Do you like it?
Read more
October 3, 2019
October 3, 2019

American CryoStem Announces:  American CryoStem Expands Investigator Team with Sub-Investigators for Post Concussive Syndrome IND

Do you like it?
Read more
September 18, 2019
September 18, 2019

American CryoStem Announces:  FDA Accepted its Investigational New Drug Application for Post Concussion Syndrome

Do you like it?
Read more
September 12, 2019
September 12, 2019

American CryoStem Engages BioSolutions Clinical Research Center, LLC. and Principal Investigator for Chronic Concussive Syndrome IND

Do you like it?
Read more
12345678
Next page